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A healthy pregnancy plays an essential role in fetal growth and development as well as future 
health. Due to the major biochemical, physiological and anatomical alterations that occur to 
the body during pregnancy, a woman’s future health is impacted by her pregnancy outcome. 
Adverse pregnancy outcomes include preeclampsia, miscarriage, spontaneous preterm birth, 
gestational diabetes mellitus, intrauterine growth restriction and preterm premature rupture 
of the membranes, all of which are associated with an increased mortality and morbidity rate 
for both mother and offspring. Therefore, it is of high importance to investigate factors that 
contribute to adverse pregnancy outcomes.  
The placenta, which is a multifunctional bridge between mother and fetus, has a dynamic 
system and its development during pregnancy is pivotal for pregnancy success. Therefore, 
factors that may impact placental structure and function can contribute to pregnancy 
outcome. Too much free radicals such as reactive oxygen species can cause oxidative stress 
when there is not enough antioxidants to neutralise them. Placental maldevelopment and 
oxidative stress contribute to adverse pregnancy outcomes. The mechanisms that underlie 
how oxidative stress may result in poor placental development require further investigation, 
particularly the role of maternal nutrition in oxidative stress and pregnancy outcome.  
Mechanistically there is little evidence defining how maternal micronutrient intake can 
impact placental development and pregnancy outcome. However, poor maternal 
micronutrient status may be associated with increased oxidative stress and inflammation. 
Selenium and iodine are two essential micronutrients that are vital for a healthy pregnancy 
and childbirth. A deficiency of selenium or iodine can cause health issues such as impaired 
executive function, thyroid dysfunction, reduced fetal growth and insufficient 
neurodevelopment in offspring and is associated with a higher risk of pregnancy 
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complications. A plethora of research on the thyroid has demonstrated that selenium and 
iodine contribute to oxidative stress but their potential synergistic effect within the placenta 
and in relation to oxidative stress has not been investigated.  
Copper is an essential micronutrient with a complex association with free radicals 
metabolism. Determination of how it may affect the placenta and its role in oxidative stress 
may provide additional knowledge to understand its association with pregnancy 
complications in population studies.   
Fetal and maternal new tissue synthesis during pregnancy needs higher energy and nutrients. 
In humans, the mitochondria metabolises macronutrients to provide energy to the cell with 
the highest efficiency. Micronutrients are involved in mitochondrial electron transport chain 
and their deficiency may result in mitochondrial dysfunction in producing energy. 
Mitochondria contain DNA and electron respiratory chain. Mitochondrial electron 
respiratory chain is a source of electron leakage and oxidative stress. Changes to the electron 
respiratory chain and mitochondrial DNA copy number have been shown in some oxidative 
stress related diseases. The question that arises is how mitochondrial DNA content may 
change in relation to maternal micronutrient status and if pregnancy outcomes are associated 
with mitochondrial DNA content.  
Telomere length is one of the markers used to predict later risk of non-communicable 
diseases and telomere length can be shortened by oxidative stress. Because maternal diet 
during pregnancy can impact offspring chronic disease incidence, a review that 
systematically summarises and discusses the literature assessing the association between 
maternal diet and offspring telomere length would reflect the available knowledge and future 




Thesis Structure / Abstract 
This thesis is comprised of seven chapters: a general thesis introduction (Chapter 1), one 
Published review of the literature (Chapter 2), one published research article (Chapter 3), 
one submitted research article (Chapters 4), one unpublished research chapter written in 
manuscript style (Chapters 5), a published systematic review (Chapter 6), and a final general 
discussion (Chapter 7). 
Chapter 2 is a published comprehensive review of the impact of maternal selenium and 
iodine on placental and child health (Habibi et al., Nutrients 2020). A few studies showed 
that selenium could increase antioxidant enzyme activity in placental cell lines. Additionally, 
population studies revealed that selenium and iodine deficiency separately were associated 
with a greater risk of pregnancy complications. However, there are no studies that have 
investigated the potential synergistic effect of iodine and selenium combined on placental 
health. To address this gap in the literature, the role of these two essential micronutrients 
during pregnancy and in relation to oxidative stress has been comprehensively reviewed. 
This review supports the hypothesis that selenium and iodine could potentially have a 
synergistic role in protecting against oxidative stress in the placenta. We went on to test this 
hypothesis in Chapters 3 and 4. 
Chapter 3 is a published original research study describing the effect of iodine and selenium 
on proliferation, viability, and oxidative stress in HTR-8/SVneo placental cells (Habibi et 
al., Biological Trace Element Research 2020). Our study showed that oxidative stress 
reduces HTR-8/SVneo cells viability and increases lipid peroxidation, which is oxidative 
damage to the cell membrane. Interestingly, selenium and iodine supplementation separately 
or together could protect cells against oxidative stress. A supraphysiological concentration 
of selenium caused some toxic effects in cells that were not exposed to oxidative stress. 
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Interestingly, the same concentration in cells treated with oxidative stress was protective 
suggesting a higher demand of selenium in HTR-8/SVneo placental cells to combat 
oxidative stress. The combination of selenium and iodine provided a greater protection 
against oxidative stress to the cells compared to their individual supplementation suggesting 
a synergistic effect in HTR-8/SVneo placental cells. 
Chapter 4 is original research describing how selenium and iodine can protect first trimester 
human placenta against oxidative stress and what the effect of copper is in the placenta 
(submitted to Human Reproduction on 19th August 2020). For the first time, using laser 
ablation inductively coupled plasma-mass spectrometry, we showed the selenium and 
copper distribution in the treated human first trimester placenta explants. We investigated 
the potential mechanism of the effect of iodine, selenium and copper on first trimester human 
placenta. Oxidative stress increased DNA damage and apoptosis and supplementation with 
iodine or selenium was protective resulting in reduced DNA damage and apoptosis in first 
trimester placenta explants. Supplementation with a combination of iodine and selenium 
provided a greater reduction in oxidative damage to DNA molecules suggesting a synergistic 
effect against oxidative stress in the placenta. A high concentration of copper increased DNA 
damage and apoptosis in the placenta in the absence of induced oxidative stress. However, 
this was not seen when placenta tissue explants were exposed to oxidative stress suggesting 
a higher consumption of copper during oxidative stress. 
Chapter 5 is an unpublished original manuscript describing associations between buffy coat 
mitochondrial DNA content and maternal micronutrient status and pregnancy outcome (To 
be submitted to the International Journal of Molecular Sciences). Using 317 samples of 
participants of Screening for Pregnancy Endpoints (SCOPE) study in Adelaide we 
investigated the association between maternal mitochondrial DNA content at 15 ± 1 weeks’ 
gestation with micronutrient status and pregnancy outcomes. We found that higher 
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inflammation, defined by increased C-reactive protein concentration, was associated with 
reduced mitochondrial DNA content. A lower mitochondrial DNA content at 15 ± 1 weeks’ 
gestation was associated with a greater risk of pregnancy complications. There was no 
association between mitochondrial DNA content and micronutrient status. Mitochondrial 
DNA content may reflect risk of pregnancy complications but it is not a strong predictor and 
it was not associated with maternal micronutrient status. 
Chapter 6 is a published systematic review on maternal diet and offspring telomere length 
(Habibi et al., Nutrition Reviews 2020). Maternal nutrition may be an important determinant 
of offspring telomere length that is a biomarker of ageing and chronic diseases. Therefore, 
we systematically reviewed all available literature about the association of maternal nutrition 
and offspring telomere length. We found little evidence on such an essential topic. However, 
there were seven studies on this topic and collectively they showed that higher maternal 
circulating folate and 25(OH)D3 and dietary caffeine intake, were associated with longer 
offspring telomere length, whereas dietary intake of carbohydrate, folate, n-3 PUFA, vitamin 
C or sodium, was not. This systematic review highlighted the necessity for further research 
in this area. 
Chapter 7 is the final chapter that presents a summary of my PhD work and general 

















A Review of the Potential Interaction of Selenium and Iodine 







“The beginning of knowledge is the discovery of something 
 we don’t understand.” 
















































































































Effect of Iodine and Selenium on Proliferation, Viability, and Oxidative Stress 
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Abstract 
Study question: Can the micronutrients selenium, iodine and copper protect human first 
trimester placenta from oxidative stress in? 
Summary answer: Selenium and iodine, alone or in combination, can protect first trimester 
human placenta against oxidative stress. Copper was not protective. 
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What is known already: Adequate maternal nutrition is vital for placental development. 
Poor placentation, imbalanced maternal micronutrient status and placental oxidative stress 
are associated with greater risk of pregnancy complications, which impact mother and infant 
health.  Selenium, iodine and copper are essential micronutrients with key roles in 
antioxidant systems. 
Study design, size, duration: First trimester (7-12 weeks of gestation) human placenta 
explants (n=15) were treated with a range of concentrations of selenium, iodine, selenium 
and iodine or copper. The concentrations represented deficient, physiological or high dose. 
After treatment, placenta explants were collected for assessment of proliferation, apoptosis 
and DNA damage. 
Participants/materials, setting, methods: Micronutrient treated placenta explants (n=3) 
were harvested, fixed, processed and embedded in paraffin blocks to be used for laser 
ablation inductively coupled plasma-mass spectrometry (LA ICP-MS) to assess selenium 
and copper uptake. Additional placenta explants (n=12) were supplemented with sodium 
selenite (0, 0.8 or 1.6 µM), potassium iodide (0, 0.5 or 1 µM), a combination of sodium 
selenite and potassium iodide, or copper (II) sulphate (0, 20 or 40 µM) for 72 hours and 120 
µM menadione or 480 µM antimycin for 24 hours to induce oxidative stress. 
Immunohistochemical labelling was performed for assessment of proliferation (Ki67), 
apoptosis (cleaved caspase-3), and DNA damage (8-hydroxy-2'-deoxyguanosine). 
Main results and the role of chance: LA-ICP-MS element imaging showed that placenta 
explants could uptake selenium and copper from the media. Sodium selenite (1.6 µM) 
increased cell proliferation (p < 0.05). Sodium selenite and potassium iodide reduced DNA 
damage and apoptosis (p < 0.05). Following oxidative stress induction, a higher 
concentration of sodium selenite (1.6 µM) was needed to reduce DNA damage and apoptosis 
while both concentrations of potassium iodide (0.5 and 1 µM) were protective (p < 0.05). A 
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high concentration of copper (40 µM) increased apoptosis and DNA damage (p < 0.05) but 
this effect was no longer significant after induction of oxidative stress by menadione or 
antimycin (p > 0.05). 
Limitations, reasons for caution: This study was only conducted in first trimester human 
placenta tissue therefore it is unknown if the impact of these micronutrients on oxidative 
stress in the placenta would be the same had the treatments occurred at different time points. 
Wider implications of the findings: Excess oxidative stress deleteriously impacts human 
placental tissue resulting in increased apoptosis and oxidative damage to DNA molecules. 
Selenium and iodine, alone and in combination, can protect the placenta against oxidative 
stress. Therefore, an optimal maternal level of micronutrients may be essential for placenta 
health and hence offspring health.  
Study funding/competing interest(s): This research was supported by National Health and 
Medical Research Council (NHMRC) GNT1161079 Targeting micronutrients to tackle 
pregnancy disorders: an integrated approach awarded to CTR, SJZ, TVP, JAG, SYL and 
TBM. CTR is supported by a NHMRC Investigator Grant GNT1174971 and a Flinders 
University Matthew Flinders Fellowship. The authors have no conflicts of interest. 
Trial registration number: NA 




Maternal nutrition during early pregnancy is critical for fetal growth and development and 
can impact the future health of the offspring later in life [1,2]. A deficiency or excess in 
micronutrients such as selenium, copper, and iodine measured in maternal plasma, serum or 
urine are associated with a greater risk of pregnancy complications such as preeclampsia, 
gestational diabetes mellitus, spontaneous preterm birth and small-for-gestational age [3-7]. 
The detrimental effects of pregnancy complications are not limited to the pregnancy as their 
long-term consequences can impact the health of both mother and child later in life [8-10]. 
Thus, it is of paramount importance to determine the nutritional risk factors related to 
pregnancy complications and devise any potential preventive strategies.  
The placenta is the key mediator of maternal nutrient supply to the fetus. Poor placental 
development, including incomplete remodelling of arteries during early pregnancy, has been 
associated with pregnancy complications like preeclampsia [11]. Partial remodelling of the 
maternal arteries causes hypoxia followed by reoxygenation which results in oxidative stress 
[12]. Oxidative stress is frequently associated with a range of pregnancy complications 
[13,14]. Oxidative stress is caused by accumulated reactive oxygen molecules and 
insufficient antioxidant activity [15,16], and results in damage of molecules such as lipids, 
proteins and DNA, thus tissue decay [16]. In addition, oxidative stress can increase apoptosis 
and this leads to high shedding of syncytial fragments into maternal blood resulting in a 
systemic inflammatory response, which is associated with pregnancy complications [17]. 
Micronutrients and oxidative stress are related through the antioxidant system [18,19]. For 
instance, glutathione peroxidase (GPx) and superoxide dismutase 1 (SOD1) are two 
antioxidant enzymes that require micronutrients for proper function [18,19]. GPx needs 
selenium and SOD1 requires copper or zinc to scavenge radicals and prevent oxidative stress 
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[18,19]. Studying micronutrient status in relation to placental development and oxidative 
stress may help elucidate the mechanisms involved in pregnancy complications. Although 
population studies have shown that selenium supplementation is associated with a lower 
incidence of preeclampsia and premature rupture of membranes [20-22], the impact of 
micronutrients on placental development is not fully understood. In addition, there is no 
information on potential interactions between selenium and other micronutrients. Iodine is 
an essential micronutrient and its deficiency during pregnancy puts both mother and 
offspring at a greater risk of pregnancy complications such as gestational hypertension, 
intrauterine growth restriction and preterm birth [7,23-27]. We recently showed that 
selenium and iodine deficiency are associated with lower cell proliferation and higher cell 
death and lipid peroxidation in HTR8/SVneo trophoblast cells [28]. In addition, individual 
or combined supplementation with selenium and iodine protected trophoblast cells against 
oxidative stress by enhancing cell viability and proliferation and reducing lipid peroxidation 
[28]. 
Copper is another essential component in a variety of metalloenzymes [29] including the 
antioxidant SOD1 enzyme [18]. High copper levels in maternal serum have been associated 
with a greater level of inflammation [3]. Investigating how copper may impact the placenta 
will help to understand its role and impact on pregnancy outcome. This study investigated 
how selenium, iodine and copper may impact oxidative stress response in first trimester 
human placenta by assessing their effect on proliferation, apoptosis, and DNA damage.  
Materials and methods 
Placenta explant tissue culture 
First trimester (7-12 weeks’ gestation; determined from last menstrual period) human 
placenta tissue samples (n=15) were collected with informed consent from women who 
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underwent elective surgical terminations at the Pregnancy Advisory Centre, Woodville, 
South Australia. Age and BMI Mean±SD of participants were 28.83 ± 7.18 year and 25.36 
± 3.38 kg/m2 respectively. Ethnicity was mainly Caucasian. None of them reported a medical 
issue for the termination.  Ethics approval was granted by the Queen Elizabeth Hospital 
Human Research Ethics Committee (HREC/16/TQEH/33).  
Within an hour of termination, 10-15 mg of placenta tissue sections (3-4 pieces) were 
cultured on a pre-prepared gel base in each well of a 48-well plate. The gel base was Growth 
Factor Reduced Matrigel® (protein concentration: 3 mg/ml; Corning®) and 1X DMEM 
GlutaMAX™ media (Gibco® Life Technologies™) containing 10% v/v FBS (Sigma-
Aldrich) and 1% v/v Antibiotic-Antimycotic (Life Technologies™) at pH 7.0. Culture 
conditions were maintained at 37oC, 5% CO2 and 1% O2 for the duration of the experiments. 
Placenta explants were first cultured for 48 hours to enable regeneration of the syncytial 
layer. Explants were supplemented with sodium selenite (Sigma Aldrich®) (0, 0.8 or 1.6 
µM), potassium iodide (Sigma Aldrich®) (0, 0.5 or 1 µM), copper (II) sulfate (Sigma 
Aldrich®) (0, 20 or 40 µM), a combination of sodium selenite and potassium iodide (0.8 µM 
sodium selenite and 0.5 µM potassium iodide), or sterile Milli-Q water for 72 hours with 
supplementation replenished every 24 hours. These concentrations represent the low, 
physiological and supraphysiological level as measured in maternal blood during pregnancy 
[3,30]. Explants were then treated with 120 µM menadione, 480 µM antimycin or 0.1% 
ethanol (vehicle for menadione and antimycin) for 24 hours. Menadione reduction can 
produce semiquinone radicals. Semiquinones are unstable and reactive substances that can 
make reactive oxygen species, therefore oxidative stress [31]. Antimycin can inhibit 
complex III in the mitochondrial respiratory chain, therefore reactive oxygen specious 
production increases and oxidative stress occurs [32]. Explants were harvested and fixed in 
10% neutral buffered formalin for 2 hours at room temperature, then washed 3 times with 
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1X phosphate buffered saline (PBS) for 24 hours at 4oC and stored in 70% ethanol at 4oC 
until processing. Explants were processed and embedded in paraffin blocks for downstream 
assessments. 
Micronutrient uptake 
To evaluate if placenta tissue explants take up selenium and copper, three first trimester 
placentas from 7-12 weeks’ gestation were cultured for 5 days including 48 hours syncytial 
layer regeneration (Jankovic-karasoulos et al, accepted pending revisions), and 72 hours of 
supplementation with (0, 0.8, 1.6 µM) sodium selenite or (0, 20, or 40 µM) copper (II) sulfate 
as above. Explants were then harvested, fixed and paraffin embedded. Tissue sections of 10 
µm were placed on microscope slides. Sections were heated for 2 hours at 60oC, then 
dewaxed with 100% xylene and 100% ethanol and washed with PBS two times and finally 
air dried overnight. Standards were made by dissolving 10% gelatine (Sigma Aldrich®) in 
elements solutions of selenium and copper with 0, 1, 10, and 100 mM concentrations. 
Gelatine blocks were mounted in Tissue-Tek OCT Compound medium. Gelatine blocks 
were cut in 10 µm sections to match placenta explant sections using a cryomicrotome (Leica 
CM3050s Cryostat). After placing gelatine sections on the microscope slides, they were kept 
at -20oC. Gelatine sections were air dried overnight before laser ablation (LA) inductively 
coupled plasma-mass spectrometry (ICP-MS) analyses (Adelaide Microscopy, University of 
Adelaide), using an attached Resolution 193 nm excimer laser ablation system coupled to an 
Agilent 7900x ICP-MS. Samples were ablated with a series of parallel lines with the 
following conditions: 23 μm spots size, 23 μm/s speed, 10 Hz repetition rate and a fluence 
of ~1 J/cm2. Intensity of micronutrients were recorded as counts per second for the following 
isotopes: 13C, 23Na, 24Mg, 29Mg, 31P, 39K, 43Ca, 57Fe, 65Cu, 66Zn and 77Se.  Only the elements 
of most interest (Se and Cu) are discussed in detail. Data was processed using the iolite data 
processing software, and concentrations were calculated and visualised relative to the 
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gelatine standards to form a 2D map of micronutrient concentration over a chosen surface of 
each placenta explant sample. 
Assessment of proliferation, apoptosis and DNA damage  
To assess the effect of supplementation on placental proliferation, apoptosis and DNA 
damage, explants from first trimester placentas (n=12) of 7-10 weeks’ gestation were 
cultured as mentioned above. Tissue sections of 5 µm were placed on microscope slides for 
immunohistochemical labelling for assessment of proliferation (Ki67; Abcam®; ab16667), 
apoptosis (cleaved caspase-3; Cell Signalling Technology® ; CST.9661L) or DNA damage 
(8-hydroxy-2'-deoxyguanosine; Abcam®; ab48508) (Table 1). A Hamamatsu NanoZoomer 
Digital Pathology slide scanner was used to scan the stained sections. Eight areas per explant 
tissue, randomly chosen using NDP.view2 software, were used for quantification and 












Table 2: Antibodies used for immunohistochemical labelling 
Antibody Dilution Target 
Species 
CAT # Company Diluent Antigen Retrieval 
Ki67 1/100 Rabbit ab16667 Abcam® 5% Goat 
serum 
Citrate buffer (10 
mM Citric acid; pH 
6.0; 10 min boiling 
in microwave, Sixth 
Sense, Whirlpool, 











Citrate buffer (10 
mM Citric acid; pH 
6.0; 10 min boiling 






1/200 Mouse ab48508 Abcam® 5% Goat 
serum 
Citrate buffer (10 
mM Citric acid; pH 
6.0; 10 min boiling 
in microwave)  
 
Statistical analyses 
Proliferation, apoptosis and DNA damage are expressed as a fold change (FC) relative to the 
control of each experiment ± standard error. To examine differences between micronutrient-
treated and non-treated groups, Generalised Estimating Equations (GEE) were used with 
log2-transformed positive stain per area to estimate fold change compared to controls. 
Independence correlation structure was assumed for the GEE to account for measurements 
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from multiple regions per explant. Pre-specified post-hoc contrasts comparing individual 
sodium selenite and potassium iodide treatments with combination of sodium selenite and 
potassium iodide were performed with Bonferroni adjustment for multiple comparisons. P-
values of less than 0.05 were considered significant. All analyses were performed using R 
version 3.5.3 or later. 
Results 
Confirmation of micronutrient uptake within the treated first trimester placenta explants 
Qualitative assessment of micronutrient distributions with laser ablation inductively coupled 
plasma-mass spectrometry (LA-ICP-MS) element imaging showed that supplementation 
with selenium and copper increased the content of these micronutrients in the placenta 
explants confirming the micronutrient uptake by explants from the media supplemented with 
selenium and copper (Figure 1, Supplementary Figure 1 and 2). In all three placentas, highest 
uptake of selenium was found in tissues treated with 1.6 µM sodium selenate indicated by 
more red and yellow pixels in the LA-ICP-MS images (Figure 1D-F, Supplementary Figure 
1D-F and Supplementary Figure 1J-L). In two placentas, it was apparent that with increasing 
selenium concentration, there was an increased uptake of selenium on the 2D map (Figure 
1D-F and Supplementary Figure 1J-L). Assessment of tissues treated with copper (II) sulfate 
showed that control tissues had the lowest level of copper visualised by dark and light blue 
pixels. All tissues supplemented with 20 µM copper (II) sulfate and two tissues 
supplemented with 40 µM copper (II) sulfate (Figure 1J-L, Supplementary Figure 2D-F and 
Supplementary Figure 2J-L) had a higher content of copper compared to the control. This 
method was not able to assess iodine uptake but the evidence for selenium and copper uptake 




Apoptosis and DNA damage induction by menadione and antimycin  
A dose response experiment (n = 3) was performed to find the optimal concentration of 
menadione and antimycin for inducing oxidative stress in first trimester human placenta 
tissue. The following concentrations of menadione (0, 60, 120, 240 µM) and antimycin (0, 
240, 480, 960 µM) were tested. Immunohistochemical analysis for DNA damage using 8-
hydroxy-2'-deoxyguanosine was used to select the optimal concentration that induced 
sufficient DNA damage compared to vehicle control in the absence of micronutrient 
supplementation. The concentrations selected were 120 µM for menadione and 480 µM for 
antimycin.  
In the 12 first trimester placenta explants used in this study, immunohistochemistry analyses 
showed that compared to vehicle control (0.1 % ethanol) 120 µM menadione and 480 µM 
antimycin, in the absence of micronutrient supplementation, significantly increased the 
number of apoptotic cells and DNA damage (p < 0.05) (Figure 2 and Supplementary Figure 
3). This confirmed that oxidative stress was induced in the cultured first trimester placenta 
explants and that this system could be used to assess whether micronutrient supplementation 
protects against induced oxidative stress. 
Effect of selenium, iodine and copper supplementation on proliferation  
Ki67 positivity was used to assess whether any of the micronutrients altered proliferation 
within the treated placenta explant tissues in the absence of oxidative stress. There were no 
changes in proliferation except for treatment with 1.6 µM sodium selenate which increased 
cell proliferation after 72 hours of supplementation (0.58, 95% CI: 0.25, 0.90) (Figure 3 A). 
When oxidative stress was induced, with menadione or antimycin, there were no changes in 
proliferation except for 1.6 µM selenium which again showed an increase in the number of 
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Ki67 positive cells per mm2 after treatment with menadione (0.63, 95% CI: 0.31, 0.95) 
(Figure 3B), or antimycin (0.39, 95% CI: 0.11, 0.67) (Figure 3C) (p < 0.05). 
Effect of selenium, iodine and copper supplementation on apoptosis  
In the absence of oxidative stress, both 0.8 and 1.6 µM sodium selenite reduced apoptosis (-
0.25, 95% CI: -0.44, -0.053 and -0.54, 95% CI: -0.83, -0.25, respectively) compared to 
control (sterile MilliQ water) (Figure 4A). Potassium iodide (0.5, 1 µM) significantly 
reduced apoptosis (-0.73, 95% CI: -1.06, -0.41 and -0.82, 95% CI: -1.18, -0.46, respectively) 
(Figure 4A). The combination of 0.8 µM sodium selenite and 0.5 µM potassium iodide also 
reduced apoptosis compared to the vehicle control (-0.68, 95% CI: -0.96, -0.4) (p < 0.05) 
(Figure 4A). In addition, the effect of the combination of sodium selenite and potassium 
iodide significantly increased apoptosis compared to individual supplementation with 0.8 
µM sodium selenite (p < 0.05) but not 0.5 µM potassium iodide. Treatment with 40 µM 
copper (II) sulfate significantly increased apoptosis (0.35, 95% CI: 0.11, 0.60) compared to 
control (Figure 4A).  
Assessment of apoptosis following induction of oxidative stress by menadione showed that 
1.6 µM sodium selenite (-1.04, 95%CI: -1.25, -0.84), both 0.5 µM (-1.34, 95%CI: -1.64, -
1.04) and 1 µM potassium iodide (-1.28, 95%CI: -1.65, -0.91), and the combination of 0.8 
µM sodium selenite and 0.5 µM potassium iodide (-1.1, 95%CI: -1.32, -0.84) were 
associated with a significant reduction in apoptosis (p < 0.05) when compared to the 
menadione alone control (Figure 4B). Combination of sodium selenite and potassium iodide 
reduced apoptosis more than 0.8 µM sodium selenite (p < 0.05) but not more than potassium 
iodide (0.5 µM) alone (Figure 4B). Copper (II) sulfate did not significantly impact apoptosis 
(p > 0.05) (Figure 4B). Similar results were seen when oxidative stress was induced using 
antimycin (Figure 4C), that is, reduction in apoptosis with the higher dose of sodium selenite 
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(1.6 µM), both potassium iodide concentrations (0.5 and 1 µM) and sodium selenite and 
potassium iodide combination but no changes in apoptosis with copper (II) sulfate compared 
to the antimycin alone control (Figure 4C).   
Effect of selenium, iodine and copper supplementation on DNA damage  
Both concentrations of sodium selenite 0.8 µM (-0.4, 95% CI: -0.6, -0.16) and 1.6 µM (-
0.65, 95% CI: -1.27, -0.02), potassium iodide 0.5 µM (-0.42, 95% CI: -0.83, -0.02), 1 µM (-
0.43, 95% CI:  -0.85, 0.01), and the combination of 0.8 µM sodium selenite and 0.5 µM 
potassium iodide (-0.73, 95% CI: -1.18, -0.29) reduced DNA damage compared to control 
(sterile MilliQ water) following 72 hours of treatment (p < 0.05) (Figure 5A). However, the 
effect of the combination of sodium selenite and potassium iodide was not significantly 
different from individual supplementation with sodium selenite or potassium iodide (p > 
0.05) (Figure 5A). There was a significant increase in DNA damage in cells treated with 40 
µM copper (II) sulfate (0.63, 95% CI: 0.17, 1.09) (Figure 5A).  
Assessment of DNA damage after oxidative stress induction with menadione showed that 
1.6 µM sodium selenite (-0.92, 95% CI: -1.44, -0.41), both concentrations of potassium 
iodide: 0.5 µM (-0.87, 95% CI: -1.49, -0.24), 1 µM (-0.85, 95% CI: -1.42, -0.27) and the 
combination of sodium selenite and potassium iodide (-0.95, 95% CI: -1.41, -0.48) resulted 
in a significant reduction in DNA damage compared to the menadione alone control while 
copper (II) sulfate did not have any significant effect (p > 0.05) (Figure 5B). While the 
combination of 0.8 µM sodium selenite and 0.5 µM potassium iodide significantly reduced 
DNA damage after menadione treatment, there was no effect with the individual 
supplementation of 0.8 µM sodium selenite (p > 0.05). In addition, no significant difference 
was found between supplementation with 0.5 µM potassium iodide and the combination of 
0.8 µM sodium selenite and 0.5 µM potassium iodide (p > 0.05) (Figure 5B). Similar results 
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were seen in DNA damage assessment of placenta explants treated with antimycin (Figure 
5C). 
Discussion 
Selenium supplementation increased proliferation and reduced DNA damage and apoptosis 
in the absence or presence of oxidative stress. This can be explained by the effect of selenium 
on the cell cycle and the antioxidant system [33,34]. Selenium stimulates transition from 
Gap 2 to mitosis phase in cell cycle and this increases cell division or proliferation [34]. The 
cell cycle is precisely monitored and damaged DNA molecules can be detected at several 
checkpoints [35]. Although checkpoints in different cell cycle phases may work differently, 
the ultimate outcome is if the DNA molecule is not repaired the cell containing damaged 
DNA cannot proliferate and undergoes apoptosis [35]. GPx 4 and TRx are seleno-antioxidant 
enzymes that can protect cells against oxidative damage such as DNA damage, therefore 
reducing apoptosis [36-38]. Notably, when placenta explants were treated with menadione 
or antimycin the lower concentration of sodium selenite could not reduce DNA damage or 
apoptosis. This suggests that under conditions of oxidative stress, cells may require a higher 
concentration of selenium for protection against oxidative damage.  
This study showed that potassium iodide could protect from oxidative damage to DNA 
molecules and reduced apoptosis. This is consistent with previous findings showing the 
protective effect of potassium iodide against oxidative stress in a placenta cell line [28,39]. 
Systemically, iodine is a radical scavenger as seen by its ability to metabolise H2O2 in thyroid 
hormone production [40]. The exact mechanisms by which iodine interacts with the 
antioxidant system in combating oxidative stress has not been clearly defined but studies 
have shown that iodine has antioxidant properties such as increasing total antioxidant status 
of human serum [41]. Iodine sufficient pregnant women (>150 µg/l urinary iodine 
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concentration) had higher activity of the enzyme SOD compared to iodine deficient women 
[24]. Interestingly, the combination of sodium selenite and potassium iodide resulted in a 
greater reduction in DNA damage in antimycin treated cells, compared to either 
micronutrient alone. This suggests that combining iodine and selenium may provide a 
stronger protection to the placenta against oxidative stress. Iodide and selenium can form 
selenenyl iodide that is a substrate for placental TRx and may increase antioxidant activity 
of TRx [42], thereby reducing DNA damage and apoptosis.  
In a prospective cohort study of 1065 pregnant Australian women, a high level of maternal 
plasma copper was associated with higher plasma C-reactive protein (CRP) concentrations 
[3]. CRP is an inflammatory biomarker that increases in oxidative stress [43] and its higher 
levels are associated with a greater incidence of pregnancy complications such as preterm 
birth [44] and preeclampsia [45]. The results of this study showed that a high concentration 
of copper increased DNA damage and apoptosis. Excess intake of copper may increase 
production of reactive oxygen species and diminish antioxidant defence systems [46], 
resulting in DNA damage and apoptosis. Interestingly, in menadione or antimycin induced 
oxidative stress the toxic effect of excess copper was not apparent. To remove reactive 
molecules and protect the cells against oxidative stress, the antioxidant system is 
overexpressed and the activity of enzymes such as SOD1 increases [47]. Therefore, these 
enzymes may require higher levels of cofactors including copper. This avoids copper being 
accumulated and causing toxic effects. 
In this in vitro study, gestational age did not make any difference in the effect of 
micronutrients on apoptosis and DNA damage. However, since oxygen pressure and levels 
of antioxidant enzymes may change from 7 to 10 week’s [48] further research with more 
explants from different gestational ages is needed.  
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A strength of this study was the use of laser ablation inductively coupled plasma-mass 
spectrometry to show that first trimester human placental explants can take up selenium and 
copper from the media. To the best of our knowledge, this is the first study that has directly 
shown that selenium and copper supplementation increases their content and distribution in 
cultured placental explants. This method cannot confirm iodine uptake. Additionally, this is 
the first study that has investigated the effect of micronutrients on placental explants’ 
proliferation, apoptosis and DNA damage in the absence or presence of oxidative stress, 
lending support to the important role of maternal micronutrient intake on placental 
development and hence pregnancy health. 
In conclusion, selenium and iodine supplementation may protect the first trimester human 
placenta against oxidative stress. An excess intake of copper is related to oxidative damage 
to DNA and apoptosis. Since oxidative stress is involved in pregnancy complications, an 
optimal level of micronutrients may help to ensure healthy placental development and hence 
reduce the incidence of adverse pregnancy outcomes.  
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Figure 1. Selenium and copper uptake in first trimester human placental explants 
Placenta explants (7-12 weeks of gestation) were supplemented with sodium selenite (A & 
D: sterile MilliQ water, B & E: 0.8 µM or C & F: 1.6 µM) or copper (II) sulfate (G & J: 
sterile MilliQ water, H & K: 20 µM or I & L: 40 µM) for 72 hours. Tissue sections (10 µm) 
were placed on microscope slides. Standards were made by dissolving 10% gelatine in 0, 1, 
10, and 100 mM solutions of selenium and copper. Laser ablation inductively coupled 
plasma-mass spectrometry (LA-ICP-MS) analyses on the standard gelatine and placental 
explant sections were analysed using a Resolution 193 nm excimer laser ablation system 
coupled to an Agilent 7900x ICP-MS. Samples were ablated with a series of parallel lines: 
23 μm spots size, 23 μm/s speed, 10 Hz repetition rate and a fluence of ~1 J/cm2. Intensity 
of micronutrients were recorded as counts per second for each isotope. Data was processed 
using the iolite data processing software, and element intensity calculated relative to the 
gelatine standards to form a 2D map of micronutrient distribution over a chosen surface of 





Figure 2. Effect of menadione and antimycin on apoptosis and DNA damage in first 
trimester human placental explants  
Explants from 7-12 weeks of gestation (n=12) were cultured for 5 days in media with 10% 
v/v FBS and 1% v/v Antibiotic-Antimycotic and then treated with 120 µM menadione, 480 
µM antimycin or 0.1% ethanol (vehicle control) for 24 hours. Immunohistochemical 
labelling for apoptosis (cleaved caspase-3) or DNA damage (8-hydroxy-2'-deoxyguanosine) 
was performed. Eight randomly selected regions per explant were used for quantification 
and statistical analyses. Data are presented as a fold change (FC) relative to control ± 
standard error. Statistical significance was assessed using Generalised Estimating Equations 
with independence correlation structure with log 2-transformed positive stain per area to 
estimate fold change compared to controls followed by pre-specified post-hoc Bonferroni 








Figure 3. Effect of selenium, iodine and copper supplementation on proliferation in 
first trimester placental explants 
Placenta explants from 7-12 weeks of gestation (n=12) were cultured for 48 hours for 
syncytial regeneration followed by supplementation with sodium selenite (0, 0.8 or 1.6 µM), 
potassium iodide (0, 0.5 or 1 µM), combination of sodium selenite and potassium iodide (0.8 
µM sodium selenite and 0.5 µM potassium iodide), or copper (II) sulfate (0, 20 or 40 µM) 
for 72 hours with supplementation replenished every 24 hours. (A) Placental explants were 
harvested following 72 hours of supplementation and proliferation assessed by 
immunolabelling for Ki67. In addition, after 72 hours supplementation, placental explants 
were treated with B) 120 µM menadione or C) 480 µM antimycin for 24 hours to induce 
oxidative stress and then assessed for proliferation. Eight randomly selected regions per 
explant were used for quantification and statistical analyses. Data presented as a fold change 
(FC) relative to control ± standard error. Statistical significance was assessed using 
Generalised Estimating Equations with independence correlation structure with log 2-
transformed positive stain per area to estimate fold change compared to controls followed 
by pre-specified post-hoc Bonferroni adjusted comparisons. * Indicates statistically different 






Figure 4. Effect of selenium, iodine and copper supplementation on apoptosis in first 
trimester placental explants 
Placenta explants from 7-12 weeks of gestation (n=12) were cultured for 48 hours for 
syncytial regeneration followed by supplementation with sodium selenite (0, 0.8 or 1.6 µM), 
potassium iodide (0, 0.5 or 1 µM), combination of sodium selenite and potassium iodide (0.8 
µM sodium selenite and 0.5 µM potassium iodide), or copper (II) sulfate (0, 20 or 40 µM) 
for 72 hours with supplementation replenished every 24 hours. (A) Placental explants were 
harvested at the end of 72 hours supplementation and apoptosis assessed by immunolabelling 
for cleaved caspase-3. In addition, after 72 hours supplementation, placental explants were 
treated with B) 120 µM menadione or C) 480 µM for 24 hours to induce oxidative stress and 
then assessed for apoptosis. Eight randomly selected regions per explant were used for 
quantification and statistical analyses. Data presented as a fold change (FC) relative to 
control ± standard error. Statistical significance was assessed using Generalised Estimating 
Equations with independence correlation structure with log 2-transformed positive stain per 
area to estimate fold change compared to controls followed by pre-specified post-hoc 







Figure 5. Effect of selenium, iodine and copper supplementation on DNA damage in 
first trimester human placental explants 
Placenta explants from 7-12 weeks of gestation (n=12) were cultured for 48 hours for 
syncytial regeneration followed by supplementation with sodium selenite (0.8 or 1.6 µM), 
potassium iodide (0.5 or 1 µM), combination of sodium selenite and potassium iodide (0.8 
µM sodium selenite and 0.5 µM potassium iodide), or copper (II) sulfate (20 or 40 µM) for 
72 hours with supplementation replenished every 24 hours. (A) Placental explants were 
harvested following 72 hours of supplementation and DNA damage assessed by 
immunolabelling for 8-hydroxy-2’-deoxyguanosine. After 72 hours of supplementation, 
placental explants were treated with B) 120 µM menadione or C) 480 µM for 24 hours to 
induce oxidative stress and then assessed for DNA damage. Eight randomly selected regions 
per explant were used for quantification and statistical analyses. Data presented as a fold 
change (FC) relative to control ± standard error. Statistical significance was assessed using 
Generalised Estimating Equations (GEE) with independence correlation structure with log 
2-transformed positive stain per area to estimate fold change compared to controls followed 
by pre-specified post-hoc Bonferroni adjusted comparisons. * Indicates statistically different 








Supplementary Figure 1. Selenium uptake in first trimester human placental explants 
Placenta explants from 7-12 weeks of gestation were supplemented with sodium selenite (A 
& D & G & J: sterile MilliQ water, B & E & H & K: 0.8 µM or C & F & I & L: 1.6 µM) for 
72 hours. Tissue sections were cut at 10 µm and placed on microscope slides. Standards were 
made by dissolving 10% gelatine in solutions of selenium and copper with 0, 1, 10, and 100 
mM concentrations. Laser ablation inductively coupled plasma-mass spectrometry (LA-
ICP-MS) analyses on the standard gelatine and placental explant sections were analysed at 
Adelaide Microscopy, University of Adelaide, using a Resolution 193 nm excimer laser 
ablation system coupled to an Agilent 7900x ICP-MS. Samples were ablated with a series 
of parallel lines: 23 μm spots size, 23 μm/s speed, 10 Hz repetition rate and a fluence of ~1 
J/cm2. Intensity of micronutrients were recorded as counts per second for each isotope. Data 
was processed using the iolite data processing software, and element intensity calculated 
relative to the gelatine standards to form a 2D map of micronutrient distribution over a 





Supplementary Figure 2. Copper uptake in first trimester human placental explants 
Placenta explants from 7-12 weeks of gestation were supplemented with copper (II) sulfate 
(A & D & G & J: sterile MilliQ water, B & E & H & K: 20 µM or C & F & I & L: 40 µM) 
for 72 hours. Tissue sections were cut at 10 µm and placed on microscope slides. Standards 
were made by dissolving 10% gelatine in solutions of selenium and copper with 0, 1, 10, and 
100 mM concentrations. Laser ablation inductively coupled plasma-mass spectrometry (LA-
ICP-MS) analyses on the standard gelatine and placental explant sections were analysed at 
Adelaide Microscopy, University of Adelaide, using a Resolution 193 nm excimer laser 
ablation system coupled to an Agilent 7900x ICP-MS. Samples were ablated with a series 
of parallel lines: 23 μm spots size, 23 μm/s speed, 10 Hz repetition rate and a fluence of ~1 
J/cm2. Intensity of micronutrients were recorded as counts per second for each isotope.  Data 
was processed using the iolite data processing software, and element intensity calculated 
relative to the gelatine standards to form a 2D map of micronutrient distribution over a 





Supplementary Figure 3. Apoptosis and DNA damage induction by menadione in first 
trimester human placental explants  
First trimester placenta tissues were cultured for 5 days in media including 10% v/v FBS and 
1% v/v Antibiotic-Antimycotic and then treated with A) and C) 0.1% ethanol (vehicle 
control) or B) and D) 120 µM menadione for 24 hours. Immunohistochemical labelling for 
A) and B) apoptosis (cleaved caspase-3) or C) and D) DNA damage (8-hydroxy-2'-
deoxyguanosine) was performed. Stained slides were scanned with a Hamamatsu 
NanoZoomer Digital Pathology slide scanner and NDP.view2 software were used for 
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Abstract: 
Mitochondrial DNA content (mtDNAc) is a biomarker of mitochondrial oxidative 
phosphorylation. Associations between mtDNAc and oxidative stress and inflammation in 
aging and chronic diseases are frequently reported. Oxidative stress and inflammation also 
contribute to pregnancy complications. Micronutrients are required for optimal 
mitochondrial structure and function and are also essential to support pregnancy health. To 
determine if mtDNAc is associated with pregnancy outcome and maternal micronutrient 
status, samples and data of 317 pregnant women from a prospective cohort study were used. 
Relative mtDNAc was measured in buffy coat using real-time quantitative PCR. Regression 
analyses were performed to examine the relationship between mtDNAc and pregnancy 
outcomes and maternal factors. Greater mtDNAc was associated with lower risk of any 
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pregnancy complication (OR 0.04, 95% CI: 0.00, 0.34). Every 1% increase in plasma C-
reactive protein concentration was associated with an estimated 5% reduction (95% CI 1% 
to 9% decrease) in mtDNAc. There was no association between maternal micronutrient 
status and mtDNAc. Reduced mtDNAc was associated with a greater risk of pregnancy 
complications but not with maternal micronutrient status.  
Keywords: mitochondrial DNA copy number, Pregnancy complication, inflammation, CRP, 
Oxidative stress, Micronutrient  
1 Introduction 
Mitochondria are essential for cell survival with continuous supply of adenosine triphosphate 
(ATP) [1]. They also are involved in promoting apoptosis and necrosis [2], modulating Ca2+ 
signalling, steroidogenesis, redox control and innate and adaptive immunity [2,3]. Of high 
importance, mitochondria can impact fertility [4]. The human mitochondrial genome is an 
extra nuclear DNA built of 16,569 DNA base pairs [5] and altered mitochondrial DNA 
content (mtDNAc) is often used as a biomarker of  oxidative stress [6]. Changes in mtDNAc 
can reflect mitochondrial dysfunction and impaired oxidative phosphorylation [7]. Altered 
mtDNAc has been reported in aging [8] and chronic diseases such as Parkinson’s disease, 
coronary heart disease, cardiovascular disease and metabolic syndrome [6,9-11]. Oxidative 
stress and inflammation contribute to aging [8] and chronic diseases [6,9,10], as well as 
pregnancy complications [12]. However, research on mtDNAc in relation to pregnancy 
outcomes is scarce and controversial [13-16]. 
Pregnancy complications including preeclampsia, preterm birth, and small for gestational 
age increase morbidity and mortality both prenatally and later in life for both mother and 
child [17-20]. Pregnancy complications have been associated with poor maternal nutrition 
[20-22] that also associates with low birth weight, insulin resistance, and cognitive 
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dysfunction in offspring [23-25]. A balanced supply of nutrients is necessary for 
mitochondrial structure and function [21]. A variety of nutrients such as B vitamins, 
coenzyme Q10, selenium, zinc and vitamin E are involved in mitochondrial electron 
transport chain and their primary or secondary deficiency may result in mitochondrial 
dysfunction such as bioenergetics failure [21]. This study aimed to investigate whether there 
was an association between buffy coat mtDNAc and pregnancy outcome or maternal 
micronutrient status. 
2 Results  
Participant characteristics reported at 15 ± 1 weeks’ gestation are summarized in Table 1. 
For 1% increase in C-reactive protein (CRP) concentration there was an estimated 5% 
decrease in mtDNAc at 15 ± 1 weeks’ gestation (95% CI 1% to 9% decrease) (Figure 1). 
Figure 2 shows the mean ± SD of mtDNAc for the different pregnancy outcomes. 
Complicated pregnancy (mean ± SD: 0.29 ± 0.10), preeclampsia [Median (IQR): 0.24 (0.17, 
0.29)], small for gestational age [Median (IQR): 0.25 (0.19, 0.31)], and spontaneous preterm 
birth [Median (IQR): 0.22 (0.15, 0.30)] had lower mean ± SD of mtDNAc compared to 
healthy pregnancy [Median (IQR): 0.313 (0.25, 0.37)] (p < 0.05) (Figure 2). Higher mtDNAc 
was associated with a lower risk of any pregnancy complication, preeclampsia, small for 
gestational age and spontaneous preterm birth adjusted for maternal age and BMI, although 
the effect was very small (Figure 3). Maternal age, BMI, smoking, alcohol intake, 
micronutrient status, and folate supplement intake were not significantly associated with 






Table 1. Participant characteristics of 317 nulliparous pregnant women 
Characteristics N (%) or Median (IQR) 
Age (y) 22 (19, 26) 
Body Mass index (kg/m2) 25.20 (22.23, 29.78) 
Ethnicity 
-Caucasian 




Alcohol drinking  
-3 months pre-pregnancy 
-First trimester 
-15 ± 1 week’ 
Yes                No 
163 (51.4)     154 (48.6) 
122 (38.5)     195 (61.5) 




 -15 ± 1 week’ 
Yes                No 
156 (49.2)     161 (50.8) 
150 (47.3)     167 (52.7) 
91(28.7)        226 (71.3)      
Folate supplement intake  
-Pre-pregnancy 
-First trimester 
-15 ± 1 week’ 
Yes                No 
112 (35.3)     205 (64.7) 
269 (84.9)     48 (15.1) 






























0.89 (0.81, 1.01) 
30.90 (21.84, 28.41) 
9.72 (8.53, 10.87) 
16.58 (12.74, 20.86) 
2.07 (1.98, 2.14) 
Maternal CRP (µg/ml) 12.24 (5.68, 21.38) 
CRP, C-reactive protein; GHT, Gestational Hypertension; GDM, Gestational Diabetes Mellitus; PE, 






Figure 1. Association between maternal CRP concentration and buffy coat mitochondrial 
DNA content. For every 1% increase in CRP there was an estimated 5% decrease (95% CI 
1% to 9% decrease) in mtDNAc. Log transformed CRP and mtDNAc data were used in 
linear regression analysis. Mitochondrial DNA content (mtDNAc) was calculated relative to 
nuclear DNA copy number (nDNAcn). Solid line indicates the geometric mean of mtDNAc 



































































































Figure 2. Buffy coat mitochondrial DNA content and pregnancy outcomes (mean ± SD). 
There was a significant difference between mitochondrial DNA contentof uncomplicated 
pregnancy [Median (IQR): 0.313 (0.25, 0.37)] with mitochondrial DNA content of any 
pregnancy complication including SGA, GHT, PE, SPTB, GDM and placental abruption 
[Median (IQR): 0.28 (0.22, 0.35)], preeclampsia [Median (IQR): 0.24 (0.17, 0.29)], small 
for gestational age [Median (IQR): 0.25 (0.19, 0.31)], spontaneous preterm birth [Median 
(IQR): 0.22 (0.15, 0.30)] (p < 0.05). Mitochondrial DNA content (mtDNAc) was calculated 













Figure 3. Predicted probability of pregnancy outcomes for a range of mitochondrial DNA 
content relative to nuclear DNA copy number, estimated from Logistic regressions. Higher  
mitochondrial DNA content was associated with lower risk of complicated pregnancies 
including SGA, GHT, PE, SPTB, GDM and placental abruption as all together as well as 
preeclampsia, spontaneous preterm birth (PTB), and small for gestational age (SGA), 












Figure 4. Association between buffy coat mitochondrial DNA content and maternal factors. 
Mitochondrial DNA content (mtDNAc) was calculated relative to nuclear DNA copy 
number (nDNAcn). Linear Regressions were used to test the association between maternal 
characteristics and mtDNAc, adjusted for maternal age and BMI except for age and BMI 
characteristics. Data are presented as a ratio of geometric mean and corresponding 95% CI. 
3. Discussion 
 
In this study, increasing CRP was associated with mtDNAc reduction. Studies in young [26], 
adult and old [27,28] populations have also demonstrated an inverse association between 
mtDNAc and CRP. The latter is a marker of inflammation and innate immune response [29]. 
Higher CRP levels are associated with oxidative stress [30] and an increased risk of 
pregnancy complications such as preterm birth and preeclampsia [31,32]. The contribution 
of oxidative stress in the pathogenesis of pregnancy complications is increasingly recognised 
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[12]. The mitochondrial DNA and electron transport chain are in close proximity to each 
other [33].  The mitochondrial electron transport chain is a source of free radicals production 
[34] and accumulation of free radicals results in oxidative stress that can cause DNA damage 
and mutation in mitochondrial DNA, and thus reduce DNA copy number [33-37]. Indeed, 
mtDNAcn reduction is a biomarker of mitochondrial dysfunction caused by inflammation 
and oxidative stress [35]. 
Pregnancy is energetically demanding due to new tissue synthesis, placental growth and 
function and fetal growth. The mitochondria play a fundamental role in providing this energy 
[38]. A high-energy requirement can increase electron transport chain activity and DNA 
replication in mitochondria [39]. Thus, mtDNAc increases during states of high-energy 
requirement [39,40]. Lower buffy coat mtDNAc was associated with a higher risk of 
pregnancy complications which is consistent with previous studies that have shown that 
reduced mtDNAc in peripheral blood cells was associated with gestational diabetes mellitus, 
preeclampsia and preeclampsia with intrauterine growth restriction [13,14]. In contrast, 
Williams et al. (2013) and Qiu et al. (2012) measured mtDNAc in whole blood collected at 
delivery and reported a higher mtDNAc in preeclamptic participants and in those who 
experienced placental abruption associated with preeclampsia [15,16]. The inconsistencies 
may be due to differences in samples since whole blood and buffy coat are not the same cell 
populations, which may contribute to a different mitochondrial DNA profile. Maternal whole 
blood contains cell free fetal DNA [41] and preeclampsia is associated with a higher 
concentration of cell free fetal DNA compared to an uncomplicated pregnancy [42]. This 
fetal DNA may contribute to the increased mtDNAcn seen in these studies. Also, Williams 
et al. (2013) and Qiu et al. (2012) collected whole blood at delivery while sampling time 
was 15 ±1 weeks’ in our study, and first trimester [13] and 32-36 weeks’ gestation [14] in 
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other studies. This suggests that more research is needed in this area assessing different 
stages of pregnancy to determine if mtDNA is a good biomarker of pregnancy outcome. 
Our data did not show any association between micronutrient status or folate supplement 
intake and mtDNAc. Previously, a study among 108 pregnant women revealed that maternal 
supplementation with either iron and folic acid or multiple micronutrients for a duration 
ranging from 20 to 197 days was associated with increased mtDNAcn [38]. Since the 
Adelaide SCOPE participants were from a low socioeconomic status population and 
socioeconomic status affects dietary intake and maternal nutritional status [43-46] more 
research in groups with diverse nutritional status is essential to elucidate the potential 
association between maternal micronutrient levels and mtDNAc. 
There were limitations with sample type, cohort size and time point measurement in this 
study. We measured mtDNAc in buffy coat, which may not be the ideal sample type for this 
purpose. Buffy coat contains different cell types that may have different mtDNAc and 
change in different pregnancy outcomes. Although cohort size was larger or close to the 
other studies, it might not be large enough to investigate all differences as some pregnancy 
complications had a small sample size. We only measured mtDNAc at one time point and 
mtDNAc may alter during pregnancy. Large cohort studies to measure mtDNAc in specific 
cells at a series of time points may provide a more comprehensive information in this field.   
      4. Material and method 
4.1 Study participants 
Participants were nulliparous women with a singleton pregnancy who were recruited to the 
Screening for Pregnancy Endpoints in Adelaide (SCOPE Adelaide) study between 
September 2005 and September 2008 at the Lyell McEwin Hospital, Adelaide, Australia 
[47]. Peripheral blood samples were collected at 15 ± 1 weeks’ gestation from 317 pregnant 
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women after written informed consent [47]. Ethics approval was granted by the Queen 
Elizabeth Hospital Human Research Ethics Committee (approval no: REC 1712/5/2008). 
4.2 Data Collection 
Maternal demographic characteristics, physical measurements and information on smoking 
and alcohol consumption were collected by a research midwife who interviewed participants 
at 15 ± 1 weeks’ gestation [48]. Plasma C-reactive protein (CRP) [49] and micronutrient 
status [50] were measured at 15 ± 1 weeks’ gestation and pregnancy complications were 
assessed at the end of pregnancy[48]. 
4.3 DNA extraction, measurement of genomic and mitochondrial DNA 
content 
DNA was extracted from buffy coat from EDTA peripheral blood samples using QIAamp 
96 DNA blood kit, QIAGEN, USA [48]. DNA concentration and purity were assessed using 
a NanoDrop One UV-Vis Spectrophotometer (Thermo Fisher Scientific™). DNA samples 
with A260/280 ratio of 1.8-2.0 were considered acceptable. mtDNAc was measured relative 
to nuclear DNAcn using the Bio-Rad CFX96 Real-time PCR detection system (Bio-Rad, 
Hercules, CA) and SsoFast EvaGreen Supermixes (Bio-Rad®) and calculated with ΔΔCq 
equation. Real-time quantitative polymerase chain reactions (qPCR) were performed in 
triplicate in 384-well plates with adding 20 ng DNA per well. Forward and reverse primers 
for mitochondrial DNA were h-mtDNA-F (D41 [nucleotide 3254–3277]): 
5’CGAAAGGACAAGAGAAATAAGG3’ and h-mtDNA-R (D56 [nucleotide 3126–
3147]): 5’CTGTAAAGTTTTAAGTTTTATGCG3’, respectively. Correspondingly, HBGF: 
5'GCTTCTGACACAACTGTGTTCACTAGC3' and HBGR: 
5'CACCAACTTCATCCACGTTCACC3' have been used as forward and reverse primers 
for nuclear DNA. Primer pair efficiencies were assessed using a five-point 1:10 serial 
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dilution starting with 10ng/μL of three different cell line DNA samples (R2=0.996, 
E=96.63%). Product size of h-mtDNA and HBG primers were 152 and 120 bp, respectively. 
Specificity of the PCR products and absence of primer dimer were ensured by melt curve 
analysis and agarose gel electrophoresis of PCR products. PCR cycling conditions were: 
98.0°C for 2 min, followed by 40 cycles of 5 s at 98.0°C and 10 s at 57.5°C, followed by 
melt curve analysis from 65.0°C to 95.0°C with a 0.5 increment for 5 s. 
4.4 Statistical analyses 
The relationship between mtDNAc and CRP was investigated using linear regression, with 
mtDNAc and CRP log-transformed to satisfy model assumptions, and results are reported as 
ratio of geometric means per 1% increase in CRP. Logistic regression was used to compare 
mtDNAc between uncomplicated pregnancy and pregnancy complications, adjusting for 
maternal age and BMI. Results are reported as odds ratios with corresponding 95% 
confidence intervals. The predicted probability of pregnancy complications was also 
obtained for a range of mtDNAc, averaged across maternal age and BMI, to assist with 
visualisation of the effect of mtDNAc. To assess associations between mtDNAc and 
maternal age, BMI, status, SES, smoking, CRP, and fetal sex linear regression was 
performed. mtDNAc was log-transformed to approximate normality, and results are reported 
as ratio of geometric means with corresponding 95% confidence intervals. P-values of less 
than 0.05 were considered significant. All analyses were performed using R version 3.6.3 or 
later.  
5 Conclusion 
Reduced mitochondrial DNA content was associated with a greater risk of pregnancy 
complications but because the effect was small, it is not a good biomarker for predicting 
pregnancy complications. Although this may support the notion of mitochondrial 
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dysfunction in pregnancy complications future large scale cohort studies targeting 
mitochondrial biogenesis and function at different time points of pregnancy, as well as 
experimental research investigating mitochondrial DNA content in plasma and the placenta 
help to understand if mitochondria DNA content can be an early biomarker of pregnancy 
complications better. 
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The work presented in this thesis has demonstrated that: selenium and iodine, alone and in 
combination are protective against oxidative stress in placental cells and tissue, increased 
inflammation is associated with reduced mitochondrial DNA (mtDNA) content, lower 
maternal buffy coat mtDNA content in first trimester is associated with risk of pregnancy 
complications, and exploring the effect of maternal nutrition on offspring telomere length, 
as a marker of future health, is needed. 
In Australia, one in four first pregnancies become complicated with preeclampsia, 
spontaneous preterm birth, intrauterine growth restriction, or gestational diabetes mellitus. 
The detrimental effects of pregnancy complications can last after childbirth and their long-
term consequences can increase morbidity and mortality for both mother and offspring, 
mainly due to an increased risk of chronic diseases later in life. An association between 
oxidative stress and pregnancy complications has frequently been shown. A defective 
placenta with partial remodelling of the arteries causes hypoxia followed by reoxygenation 
that results in high reactive oxygen species production and ultimately oxidative stress. 
Therefore, investigations into the effects of different factors on placental development and 
oxidative stress should be of high importance in research on pregnancy complications. 
A balanced maternal diet during pregnancy is critical for fetal growth and development as 
well as their health throughout life because of the role of in utero exposures in the 
programming of chronic diseases. Because of the fundamental role of micronutrients in the 
antioxidant system, maternal intake of micronutrients may be associated with oxidative 
stress during pregnancy. Maternal intake may also impact offspring telomere length, a 
biomarker of chronic diseases. It is also important to investigate how maternal nutrient levels 
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may influence mtDNA content because the mitochondria is the power house of the cell and 
its dysfunction is related to oxidative stress.  
Selenium and iodine are essential micronutrients and their deficiency has been associated 
with a greater incidence of pregnancy complications in population studies. Besides, selenium 
is a part of antioxidant enzymes and selenodeiodinases. Selenodeiodinases are involved in 
iodine metabolism suggesting the potential cooperation between selenium and iodine in 
biochemical reactions inside the cell and tissues. Copper is an essential micronutrient that 
plays a pivotal role in superoxide dismutation in antioxidant defence system, but its high 
level in maternal specimens was associated with greater risk of inflammation. Inflammation 
and oxidative stress can create a defective ongoing cycle in pregnancy complication 
initiation and progression. Therefore, three chapters of this thesis (2, 3 & 4) discuss the role 
of selenium, iodine, their combination, and copper in placental development and oxidative 
stress. 
We comprehensively summarised the evidence that shows the importance of adequate 
selenium and iodine during pregnancy and their effects on offspring health, as well as their 
association with pregnancy complications (Chapter 2). Then, the potential synergistic role 
of selenium and iodine in protecting cells against oxidative stress in the placenta was 
hypothesized (Chapter 2). This highlighted the necessity of further study on the effect of 
selenium and iodine separately and in combination on placental cells and tissues. 
While a deficiency of selenium and iodine in HTR-8/SVneo placental cells was associated 
with a higher level of oxidative damage, their supplementation increased cell viability and 
protected cell integrity assessed by reducing lipid peroxidation of cell membranes (Chapter 
3). Although individual iodine supplementation was not associated with a significant change 
in cell viability, supplemented cells with the combination of selenium and iodine had greater 
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viability compared to selenium treated cells. In addition, a combination of selenium and 
iodine provided a greater reduction in lipid peroxidation than their individual 
supplementation. These findings suggest a synergistic effect of selenium and iodine in 
combating oxidative stress in HTR-8/SVneo cells. A high concentration of selenium 
increased cell death and lipid peroxidation but was no longer toxic under conditions of 
induced oxidative stress. On that note, cells exposed to oxidative stress may need increased 
amounts of micronutrients to survive (Chapter 3).  
Our findings were reproducible in first trimester human placenta (Chapter 4). Due to the 
contribution of copper in the antioxidant system and report that high maternal copper levels 
are associated with greater oxidative stress and inflammation we explored the role of copper 
in relation to oxidative stress in the placental tissue as well. We used laser ablation 
inductively coupled plasma-mass spectrometry to see if there was uptake of the 
micronutrients used to supplement the cultured placenta tissues. To the best of our 
knowledge, this study was the first to show the direct assessment of micronutrient uptake in 
the placental explants. Selenium and copper content were higher in supplemented placental 
tissues compared to vehicle control confirming micronutrient uptake in first trimester 
placenta explants upon supplementation of the culture media (Chapter 4). 
Similar to HTR-8/SVneo cells, oxidative stress caused higher apoptosis and DNA damage 
in selenium and iodine deficient placental explants. Selenium supplementation increased 
proliferation and reduced DNA damage and apoptosis. Iodine protected placental explants 
against oxidative damage with reducing apoptosis and DNA damage. In oxidative stress 
induced tissues, a lower concentration of selenium was not protective suggesting a higher 
demand of selenium under oxidative stress conditions. In addition, a combination of low 
doses of selenium and iodine provided a significant protection against oxidative stress, 
perhaps because iodine may increase the antioxidant effect of selenium by enhancing its 
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availability to antioxidant enzymes such as thioredoxin reductase. A high concentration of 
copper was toxic to the placenta explants measured by increased DNA damage and 
apoptosis. However, such an effect was not apparent under conditions of oxidative stress 
suggesting a higher consumption of copper in oxidative stress, perhaps by superoxide 
dismutase, which is an antioxidant enzyme. Therefore, an optimal level of micronutrients 
are essential to protect the placenta from oxidative stress (Chapter 3 & 4). 
Adverse maternal exposures can shorten offspring telomere length, which is associated with 
a higher incidence of chronic disease later in life. A number of nutrients affects telomere 
length possibly through mechanisms such as inflammation, oxidative stress, DNA damage, 
and DNA methylation. We only found a few studies on this important topic and were unable 
to make a clear conclusion (Chapter 6). However, higher maternal circulating folate and 
25(OH)D3 and dietary caffeine intake were associated with longer offspring telomere length, 
while dietary intake of carbohydrate, folate, n-3 PUFA, vitamin C or sodium was not. This 
is a big gap in this field and further research including longitudinal studies in large cohorts 
of pregnant women are required (Chapter 6). 
The fact that pregnancy complications affect maternal and offspring health during their 
entire life lends support to the need to find early biomarkers of pregnancy complications so 
that prevention strategies can be used in early pregnancy. Changes in mtDNA content can 
reflect mitochondrial dysfunction, inflammation and oxidative stress in aging, chronic 
diseases such as Parkinson’s, coronary heart disease, cardiovascular disease and metabolic 
syndrome. We found that reduced buffy coat mtDNA content in early pregnancy was 
associated with inflammation and a greater risk of pregnancy complications however; 
because of weak power of prediction, it is not a suitable biomarker (Chapter 5). Additionally, 
we investigated how maternal micronutrient levels may be associated with mtDNA content. 
Mitochondria in mammalian cells provide the greatest amount of energy from 
149 
 
macronutrients. Pregnancy has a high level of energy demand due to increased metabolism 
and new tissue synthesis. Micronutrients are essential for mitochondrial oxidative 
phosphorylation. Therefore, micronutrient deficiencies may impair mitochondrial energy 
production. We did not find any association between buffy coat mtDNA content and 
maternal micronutrients status. However, further larger cohort studies using maternal plasma 
and placenta can help to investigate the potential association more comprehensively (Chapter 
5).   
In summary, we reviewed the literature on selenium and iodine and highlighted the need to 
investigate their potential synergistic effect on placental health and oxidative stress (Chapter 
2). We demonstrated that selenium and iodine individually and in combination are protective 
against oxidative stress in a placental cell line (Chapter 3) and first trimester human placenta 
explants, while a high concentration of copper increased oxidative damage (Chapter 4). 
Therefore, a balanced concentration of micronutrients is vital to maintain placental health 
and combat oxidative stress (Chapter 3 and 4). We determined that reduced buffy coat 
maternal mtDNA content in early pregnancy is associated with a greater risk of pregnancy 
complication but not maternal micronutrient status (Chapter 5). We highlighted that further 
research, including longitudinal studies investigating the association between maternal diet 
during pregnancy and offspring telomere length is required because of the importance of this 








Limitations and Future Directions 
1- We assessed the effect of three essential micronutrients on placental health and 
oxidative stress. Including more micronutrients can provide a more comprehensive 
knowledge of their effects and potential interaction or synergistic effects toward the 
oxidative stress and placental health. 
2- Oxidative stress and inflammation have a positive feedback loop. Investigation of 
the effect of micronutrients on inflammation and other potential mechanisms in 
pregnancy complications will enhance our understanding of the effect of maternal 
nutrition on pregnancy complications.   
3- We could only explore the effect of micronutrients on oxidative stress in first 
trimester human placenta. Continued research on a group of micronutrients in the 
placenta samples from other trimesters can address the potential differences across 
gestation. 
4- Using laser ablation inductively coupled plasma-mass spectrometry in the 
assessment of micronutrients uptake is novel. Further research including coupling 
this method with immunohistochemistry or immunofluorescence labelling of 
different placental cell types as well as quantifying micronutrients uptake in the 
placental explants opens a new avenue in studies related to micronutrients and the 
placenta. 
5- We measured mitochondrial DNA content in buffy coat of 317 samples. 
Mitochondrial DNA content assessment in large scale cohort studies using plasma 
and the placenta samples may help to determine if mitochondrial DNA content is 
associated with maternal factors such as micronutrient status and can be an early 
biomarker of pregnancy complications. 
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6- We found that investigation of the association between maternal diet and offspring 
telomere length is essential and currently lacking. Exploring this association with 
further research including large cohort studies may help to develop an early 
biomarker to identify children at risk and intervene for chronic disease prevention or 
for closer monitoring if they are at higher risk. 
7- Mitochondrial DNA content and telomere length may change across gestation. 
Perhaps this is one of the reasons that the comparison of current findings with 
previously published studies are not completely possible. There is not enough 
research that shows their alteration during healthy and complicated pregnancy. This 
can be addressed by assessment at different time points during pregnancy (ie. 






















































































Placenta Collection Protocol (Chapter 4) 
1) Use a scalpel blade to cut open the specimen sock/collection container to access the 
placenta 
2) Take 3-4 petri dishes (eg. 2 bottoms and a lid) and fill with cold 0.9% NaCl 
3) Using forceps, move pieces/chunks of tissue onto the first petri dish and wash out 
excess blood by moving tissue back and forth in the solution. Move the washed tissue into 
next petri dish of 0.9% NaCl and repeat (so it undergoes 3-4 washes depending how bloody 
the sample is) 
4) Label tube with:  
- Date 
- Gestational age 
- Study code (PAC###) 










Harvesting Placenta Explants (Chapter 4)  
1. Remove the media that is covering the explants 
2. Using an appropriate pipette gently suck the explant and place into a cassette. 
3. Place the cassette into 10% Formalin for 2-4 hours. 
4. Transfer the cassette to 1x PBS for 24 hours @ 4°C.  
5. Repeat step 4 
6. Repeat step 4 again 
7. Once you have harvested all of your explants place your cassettes in 70% ethanol for 
minimum 2 hours @ 4°C and then take to histology for embedding (cassettes can stay in 



































Supplementary Figure 1. Association between buffy coat mitochondrial DNA content and 
pre-pregnancy and pregnancy maternal dietary intake. A research midwife collected dietary 
intake of the (A) one month prior to conception and (B) during pregnancy with food 
frequency questions for fruit, green leafy vegetables, and fish at 15 ± 1 weeks’. 
Mitochondrial DNA copy number (mtDNAcn) was calculated relative to nuclear DNA copy 
number (nDNAcn). Linear Regressions were used to test the association between maternal 
dietary and mtDNAc, adjusted for maternal age and BMI. There was no association between 
maternal dietary intakes and mtDNc. Data are presented as a ratio of geometric mean and 





















PRISMA checklist (Chapter 6) 
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